Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO)

Q: What does CUSIP 984015602 represent in this 13F holders report?

CUSIP 984015602 is the security identifier for XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share in Q4 2025?

11 institutional investors reported XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 984015602

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 2,291,515
Total 13F shares: 228,794
Share change: +170,656
Total reported value: $496,638
Price per share: $2.17
Number of holders: 11
Value change: +$355,037
Number of buys: 7
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 984015602?
CUSIP 984015602 identifies XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2025

Recent filing periods for CUSIP 984015602:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) as of Q4 2025

As of 31 Dec 2025, Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 228,794 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, DRW Securities, LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), JTC Employer Solutions Trustee Ltd, CITIGROUP INC, Alexis Investment Partners, LLC, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.